The results today have validated managements thoughts re 2591 today, our management are first class, make no mistakes this 2591 asset if Taken Over is going for top dollar, the potential here is massive for a BP, Jon and team know that there is no way they will let this go go peanuts, it’s a ground breaking drug that deserves an absolute premium to be paid!!!!
I don’t think there will be an issue achieving a premium as I think there will be multiple parties after 2591!
- Forums
- ASX - By Stock
- M&A
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.54%
!
$12.92

The results today have validated managements thoughts re 2591...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.92 |
Change
0.070(0.54%) |
Mkt cap ! $1.607B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.85 | $8.049M | 616.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4175 | $12.91 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.03 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4175 | 12.910 |
4 | 4488 | 12.900 |
2 | 1762 | 12.890 |
2 | 3348 | 12.880 |
1 | 1508 | 12.850 |
Price($) | Vol. | No. |
---|---|---|
13.030 | 100 | 1 |
13.040 | 6060 | 2 |
13.050 | 1508 | 1 |
13.060 | 7205 | 8 |
13.080 | 1508 | 1 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online